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Salmonellosis  Control:  Estimated  Economic  Benefits 
Tanya  Roberts  (202-786-1864) 
Salmonellosis,  a  common  human  intestinal disorder primarily caused  by 
contaminated  meats  and  poultry,  attacks  an  estimated  two  million Americans 
annually.  Using  a  cost of  illness approach,  the  medical  costs  and  productivity 
losses  alone  were  estimated  to  cost around  one  billion dollars  in  1987.  If 
pain and  suffering,  lost leisure  time,  and  chronic  disease  costs  could  be 
quantified,  the  estimate would  increase significantly.  Other  procedures  for 
calculating  the value  of  life could either raise or  lower  the  estimated  economic 
benefits  of  reducing  human  salmonellosis. 
Incorporating  losses  to  farmers,  whose  animals  have  reduced  feed  efficiency, 
reduced  weight gain,  or deaths  because  of  chronic  salmonellosis,  would  also 
ihcrease  the  estimates.  Also  excluded  \~ere costs  of  food  safety regulatory 
programs  and  costs  to  the  industry for  product recalls  and  plant closures  due 
to  foodborne  salmonellosis  outbreaks. 
The  National  Academy  of  Sciences  has  endorsed  risk assessment  as  a  necessary 
method  to  evaluate and  improve  food  safety  regulatory  programs,  especially as 
applied  to  Salmonella  contamination of  poultry.  Understanding  the  costs  of 
salmonellosis  is an  important part of  risk characterization since  a  key  benefit 
of  regulatory  programs  is reducing  human  salmonellosis. 
Key  words~ .  Salmonella,  salmonellosis,  foodborne  disease costs,  economic  costs, 
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Introduction 
Foodborne  disease,  such  as  the  intestinal disease  salmonellosis,  results 
when  two  events  occur:  1)  Food  is contaminated  by  organisms  pathogenic  to 
humans,  and  2)  These  pathogens  are  not killed  by  cooking,  salting,  or  some 
other  means  and  their  numbers  may  actually be  increased  by  insufficient cooking 
or  insufficient refrigeration  (Bryan).  Foods  containing  animal  or  seafood 
proteins  are  more  likely  to  contain  human  pathogens  than fruits  and  vegetables, 
consequently  the  meat  industries  must  be  alert  to  the  potential contamination 
in  their  products. 
The  possibility of  a  poor  quality  product,  such  as  contaminated  food, 
does  not  by  itself indicate  a  problem  that cannot be  corrected  by  the  marketplace. 
Product quality is  one  of  the  market  parameters.  If you  don't  like  the  performance 
of  the  product,  you  can  either ask  for  your  money  back  or  ask  for  a  replacement---
actions  firmly  supported  by  the  legal  system.  Or  you  can  change  your  purchasing 
or  use  patterns.  For  example,  consider  remedies  to  stawberries  which  mold  the 
day  after purchase:  you  can  refuse  to  buy  the  product  in  the  future  (give  up 
strawberries)  or  change  your  use  practices  (buy  strawberries  only  when  you 
plan  to  use  them  that day)  or  change  stores  (maybe  another  store  buys  fresher 
berries  and  handles  them  to  extend  shelf-life)  or  switch  to  a  higher quality 
product or another  product  (frozen strawberries)  that will  perform  to  your 
satisfaction.  All  these  actions  are  market  solutions  to  the  problem  of  inferior 
products  and  result in sales  signals  sent back  to  producers. 
The  problem with  contaminated  food  is  information about product  performance. 
You  cannot always  tell whether  what  you  ate  or  something  else  made  you  sick. 
1)  Most  of  the  people  in salmonellosis  outbreaks  think  they  have  the  stomach 
flu,  not  salmonellosis  (R.  V.  Tauxe,  1987,  personal  communication).  2)  If you 
do  make  the  connection  to  a  foodborne  illness,  you  cannot always  identify 
which  food  made  you  sick.  For  example,  the  average  time  until onset of  disease • 
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for  campylobacteriosis  (another  intestinal disease associated  with  poultry) 
is  3-4  days,  and it may  be  up  to  a  week  before  you  become  ill.  3)  Even  if 
you  do  know  what  food  is  likely  to  have  made  you  ill,  most  of  the  time  it 
has  been  eaten or  thrown  out  and  is not available  for  testing  for  contaminants. 
(Epidemiological  surveys  may  be  able  to  track  down  the  disease  source,  but 
only at great expense). 
Because  the  connection  between  food  and  disease  is difficult to  make, 
corrective market  signals are not sent back  to  producers.  In fact,  producers 
get signals  that  they  don't need  to  correct  the  problem!  After a  foodborne 
disease  episode,  people  do  not stop  purchasing  what  made  them ill (because 
they  don't know  what it is).  Quantities  and  prices  of  the  foods  causing 
illness  do  not fall.  Grocery  stores  and  restaurants  seldom  receive  complaints. 
Less  frequently  does  a  beef,  chicken,  or  pork  slaughter plant hear about 
diseases  their products  may  have  caused.  Farmers  raising  these  animals  hear 
even  less  frequently.  This  lack  of  communication  does  not mean  a  lack  of 
foodborne  disease.  It means  a  lack  of  an  understanding  of  the  seriousness 
of  foodborne  disease.  It means  a  lack  of  incentives  to  change  production 
and  handling  practices  to  minimize  contamination  of  food  with  human  pathogens 
such  as  Salmonella,  Campylobacter,  Trichinella,  Toxoplasma,  Taenia,  Staphylococcus, 
Bacillus,  and  Clostridium  (National Research Council,  1985).  Food  safety is 
a  classic example  of  a  market  failure  due  to  imperfect  information:  consumers 
become  ill but producers  do  not see  a  fall  in purchases.  Consequently, 
producers  do  not  change  their practices  and  foodborne  disease  is not  reduced. 
This  lack  of  information has  another  dimension.  Consumers  cannot easily 
take  preventive actions  and  avoid  contaminated  products.  They  cannot  look 
at a  chicken  leg  in a  grocery  store,  a  chicken salad  sandwich  in a  delicatessen, 
or chicken kiev in a  restaurant and  choose  only  those  products  which  will not 
make  them  ill.  Because  of  the  information  problem,  as  a  society we  have -4-
delegated  food  safety regulation  to  federal  and  state governments.  Even  the 
regulators  have  trouble detecting  microscopic  pathogens  as  the  National  Academy 
of  Sciences  pointed out  (National Research Council,  1987). 
Methodology 
Risk  assessment,  the  backbone  of  the  Hazard  Analysis at Critical Control 
Points  system  recommended  by  the  National Research  Council  of  the  National 
Academy  of  Sciences  (1983,  1985,  1987),  has  not  been  systematically applied  to 
salmonellosis  caused  by  food.  Risk  assessment  includes  examining  the  potential 
entry  points  of  Salmonella  into  food  from  farm  to  table  and  estimating  the 
hazards  to  humans  in  terms  of  exposure,  illness,  and  resulting  costs. 
Foodborne  illness  arises  out of  a  market activity  such  as  purchasing 
meat  or  poultry at a  supermarket  or  a  restaurant and  consuming  it (Fig.  1). 
This  exposes  the  individual  to  a  risk or hazard,  namely  the  possibility of 
acquiring  a  foodborne  illnes.  Only  some  of  the  exposed  persons  become  ill. 
The  costs  associated  with  the  illness  include  costs  imposed .on  the  parties 
in  the  market  transaction--the  person  becoming ill from  buying  and  consuming 
the  product  and  the  firm  selling  the  product  (Fig.  1).  The  monetizable  costs 
include  lost wages  and  medical  costs  for  the  sick  person and  lost sales,  product 
recall and  costs  associated  with  legal  liability suits  for  the  restaurant or 
supermarket.  In addition,  there are  the  nonmonetizable  costs  such  as  the  pain 
and  inconvenience  of  the ill person who  purchased  the  food. 
Other  costs  are  imposed  on  parties  outside  of  the  market  transaction; 
they  did not buy  and  consume  the  food  and  did  not  become  ill.  An  example  of  a 
monetizable  cost is  the  expense  of  travel  to visit a  hospitalized  family  member 
or friend.  Again  the  most  obvious  nonmonetizable  cost is  the  stress  and 
disruption of  having  an ill family  member. • 
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The  cost of  illness approach  used  here  is  limited  to  evaluating  two  components 
of  human  illness costs:  medical  costs  and  lost productivity.  Omitted  from  the 
analysis  are  estimates  of  the  costs  of  pain and  suffering,  reduction of  leisure 
time  choices,  and  other costs  to  individuals  (Fig.  1).  Industry  costs  of 
reduced  animal  performance  or  product recall and  plant cleanup  during  a  foodborne 
disease  outbreak are also  omitted  as  well  as  the  cost of  the  public health 
surveillance  system. 
Three  estimates  of  human  salmonellosis  cases  are available  from  the  Centers 
for Disease  Control  (CDC)  in Atlanta: 
1)  Outbreak  data  for all foodborne  diseases  which  are  primarily 
reported  by  state health departments:  salmonellosis  typically has 
around  50  outbreaks  and  around  2,000  associated  cases  annually. 
2)  Salmonellosis Surveillance Activity which  are  reported  by  private 
and  public health workers:  averages  about 40,000  cases  annually. 
3)  Extrapolations  from  the  outbreak  and  surveillance data  by  CDC 
to estimate  the  "true"  incidence  of  salmonellosis  which  ranges 
from  400,000  to  4,000,000  human  cases  annually  (Cohen  and  Tauxe, 
1986). 
Both  outbreak  data  and  surveillance data are clear underestimates.  Infection 
may  not  be  suspected,  cultured,  diagn6sed  or  reported  for  a  variety  of  reasons. 
Community  surveys  during  outbreaks  suggest  that  the  proportion  of  actual  infections 
reported are  between  1  in  10  and  1  in  100.  Thus  CDC  estimates  that  between 
400,000  and  4,000,000  cases  may  occur annually  (Cohen  and  Tauxe,  1986).  CDC's 
"best estimate"  is  2  million salmonellosis  cases  annually  (Bennett,  Holmberg, 
Rogers,  and  Solomon,  1987). 
Individuals vary greatly in their susceptibility  to  salmonellosis  depending 
partly on  the  virulence  of  the  organism  (there are  over  1,500  Salmonella  serotypes) 
and  partly on  the  individual's  immune  system along  with  other factors.  As  few 
as  10  Salmonella cells  per  gram  or milliliter of  food  have  caused  human  illness 
(Mulder,  1982).  Typically,  Salmonellacaused disease  in  humans  is  limited  to 
salmonellosis,  an acute  gastroenteritis  which  appears  12  to  74  hours  after -6-
eating  contaminated  food.  Salmonellosis  may  cause  only  mild  abdominal  discomfort 
with minimal  diarrhea  lasting  less  than  a  day.  More  acute  symptoms  of  disease 
include  nausea,  stomach  ache,  vomiting,  diarrhea,  cold chills,  fever,  and 
exhaustion.  The  symptoms  of  disease  normally  persist for  2  to  6  days,  but in 
exceptional  cases  for  several  weeks.  A small  percentage  of  the  people  who 
contract salmonellosis  die  from  it.  Those  most vulnerable are  the  sick,  those 
taking antibiotics,  infants,  and  the  elderly.  In  rare  cases  Salmonella,  like 
many  other bacterial  and  parasitic infections,  can  cause  chronic  disease  syndromes 
(Mossel,  1984;  Cohen  and  Tauxe,  1986;  Archer,  1984,  1985). 
Because  of  the variety  of  severities  for  salmonellosis  cases,  the  estimated 
two  million cases  are  divided  into four  categories:  deaths,  hospitalizations, 
persons  seeing  a  doctor  but not hospitalized,  and  those not seeking  medical 
attention.  Both  a  high  and  a  low  estimate are  calculated for all four  severity 
categories.  One  estimate is based  on  Salmonella  outbreak data  and  the  other 
estimate  based  on  Salmonella  surveillance 4ata. 
Costs  estimates  for  the  three  illness severities  (excluding  deaths)  are 
taken  from  Cohen  et. al.'s study  (1978)  and  updated  using  various  price  indices 
for  medical  care  and  wages  published  by  the  Bureau  of  Labor  Statistics,  U.S. 
Department  of  Labor  (Table  2).  I  do  not know  how  representative  these  costs  are, 
but  they  are  the  only  costs  in  the  literature. 
To  be  consistent with  consumer  behavior  theory,  public  programs  for  reducing 
risks  of  premature  death  should  determine  what  people  are willing  to  pay  to 
reduce  the  risk of  death.  However,  economists  are still debating  how  to  measure 
this.  Fisher,  Chestnut,  and  Violette  (1986)  reviewed  six surveys  where  people 
were  asked  how  much  they  would  be  willing  to  pay  to  have  less  risk  in  their 
jobs.  From  their replies  a  monetary  value  for  risk reduction was  calculated. 
Fisher,  Chestnut,  and  Violette  concluded  that  the  results were  relatively 
consistent with  each other and  indicate  a  value  of  a  statistical life saved  of -7-
$1.6  to  $8.4 million.  However,  Gerking's  research  (1987)  indicates  that people 
give  overestimates  in such  surveys  compared  to  actual market  purchases.  Because 
of  the  lack  of  consensus,  I  am  not using  this  method. 
The  time-honored  method  of  valuing  the actuarial  loss  of  someone's  death 
is  the  human  capital  method  pioneered  by  Dorothy  Rice.  An  individual  is valued 
by  the  wages  they  would  have  received  over  the  remainder  of  their lifetime. 
The  courts  have  used  this  method  extensively  to  make  the  family  whole,  i.e. 
replace  the  lost earnings  of  a  family  member.  Recently  the  cost of  housekeeping 
services  that would  have  been  performed  by  the  deceased  person  (such  as  the 
cost of  a  cleaning  service)  have  been  added  to  the  estimates. 
Landefeld  and  Seskin  (1982)  have  adjusted  the  human  capital  method  to 
make  it more  consistent with  individual  preferences  and  what  people  are willing 
to  pay  to  reduce  risk.  Income  available  to  pay  for  risk  reduction is  expanded 
to  include non-labor  income,  such as  earnings  from  real estate and  stocks  and 
bonds,  as  well  as  wages.  The  interest rate reflects  the  individual's  (not 
society's)  opportunity cost of  investing  in risk  reducing activities,  such  as 
buying  smoke  alarms,  and  is estimated at  3%.  A risk aversion factor  is  added 
since  studies  have  shown  that households  are willing  to  pay  more  than  their 
actuarial  loss  for  other household  risks,  for  example  fire  insurance.  The 
risk aversion factor  used  by  Landefeld  and  Seskin  increases  the  estimates  by 
60%.  The  adjusted  human  capital value  of  life formula  is: 
T  t 
value  of  life =  lL:  Y tl  (1 +  r)  J  a; 
t=O 
where  T  = remaining  lifetime 
t  = a  particular year 
Yt  = after-tax income  including  labor  and  nonlabor  income 
r  =  household's  opportunity cost of  investing  in risk-reducing activities 
a;  = risk aversion factor 
Landefeld  and  Seskin's adjustments  increase  the  value  of  avoiding  death  estimates 
roughly  fourfold  for  salmonellosis  deaths  when  compared  to  the  unadjusted -8-
human  capital  method  (Roberts,  1985).  Because  Landefeld  and  Seskin only  include 
financial  losses  associated  with death  and  omit  psychic  costs  such  as  pain and 
suffering  and  the  value  of  lost  l~isure time,  the  value  of  life lost is  under-
estimated.  Because  I  use  their estimates,  the  value  of  life in  this  paper  is 
also  underestimated. 
Human  Salmonellosis  Cost  Estimates 
Total  costs  depend  upon  disease  severity.  The  salmonellosis  cases  are 
divided  into  four  severity classes:  deaths,  hospitalized  cases,  cases  in which 
a  doctor  is consulted  either in their office or an  emergency  room  (but not 
admitted  to  the hospital),  and  mild  cases  averaging  a  couple  days  of  illness 
which  may  include  some  time  off  work  but no  doctor visit. 
Deaths:  Death certificate data  showed  only  79  deaths  due  to  salmonellosis 
in  1979  (Public  Health Service,  1984).  Death certificate information is very 
inaccurate  for  two  reasons.  They  are filled out within hours  of  death and  not 
updated  with  laboratory  tests  showing  the  causative  organism.  Even  autopsy 
data  is not subsequently entered  on  the  death certificate. 
CDC  estimates actual  deaths  from  salmonellosis  in  two  ways.  One  method 
uses  the  salmonellosis  surveillance data.  A stratified sample  of  counties 
have  periodically been  surveyed  for  more  detailed  information.  In  the  1979-80 
survey  1.4%  died  and  in  the  1984-5  survey  1.3%  died  which  provides  an  estimate 
of  500  deaths  per year for  the  40,000  reported cases  (Cohen  and  Tauxe,  1986). 
Since  the  40,000  reported  cases  are  only  a  fraction  of  the  estimated  2  million 
cases  that occur,  the  number  of  deaths  is  doubled  to  an  estimated  1,000  annually 
(R.V.  Tauxe,  1987,  personal  communication). 
The  other method  uses  data  from  outbreaks  of  foodborne  disease  due  to 
salmonellosis.  In outbreaks  where  virtually all cases  have  been  identified, 
typically 1/1,000  cases  dies.  Multiplying  this  ratio  by  the  estimated  2  million -9-
cases  results  in an  estimated  2,000  deaths  annually  (Bennett,  Holmberg,  Rogers, 
and  Solomon,  1987). 
Most  of  reported  deaths  are  elderly  people  and  a  few  infants  (Public  Health 
Service,  1984).  Assuming  this  reported  age  distribution is  representative for 
all estimated  salmonellosis  deaths,  then it can  be  combined  with Landefeld  and 
Seskin's  numbers  to  estimate  the  benefits  of  reducing  health  risks  from  salmonellosis. 
Updated  to  August  1987  values  using  the  Average  Weekly  Earnings  Index,  todays' 
value  for  the  stream  of  productivity  lost for  each  premature  salmonellosis 
death  is  $354,600.  Multiplied  times  the  1,000  to  2,000  estimated  deaths,  the 
loss  due  to  premature  death  is  estimated  to  range  from  $355  million  to  $709 
million annually  (Table  1). 
Hospitalized cases:  Again  the  two  methods  for  estimating  the  number  of 
people hospitalized are  extensions  of  the  national  salmonellosis  surveillance 
data  and  foodborne  outbreak data.  Cohen  and  Tauxe  (1986)  report  that an  estimated 
18,000  of  the  40,000  reported  salmonellosis  surveilance  cases  are hospitalized 
annually.  Again  because  the  40,000  reported  cases  are  only  a  fraction of  the 
estimated actual  2,000,000  cases,  the  number  of  hospitalized  cases  is  doubled 
to  estimate  36,000  hospitalizations for  salmonellosis  annually  (R.V.  Tauxe, 
1987,  personal  communication). 
Outbreak  data  estimation comes  from  the  1985  Illinois salmonellosis  outbreak 
due  to  pasteurized milk.  Hospitalized  cases  numbered  2,777.  The  hospitalization 
rate for  the  outbreak  is  2,777  hospitalizations  divided  by  the  183,186  total 
estimated  cases  for  the  Illinois outbreak,  or  1.52%  (Ryan et al.,  1987). 
MUltiplying  this  percentage  by  the  U.S.  annual  estimated  cases  of  salmonellosis 
results  in an  estimated  30,000  hospitalized cases  (.0152  x  2,000,000  = 30,000 
rounded  to  the nearest  thousand). 
Costs  are  not yet available  from  the  Illinois  outbreak  so  Cohen  et al.'s 
costs  (1978)  are  updated  to  October  1987  values  using  the  Hospital  Room  component -10-
of  the  Consumer  Price  Index  (Table  2).  The  cost for hospitalized  cases  is 
estimated  to  be  $4,350.  Multiplied  times  the  number  of  hospitalizations  results 
in  these  cases  costing  an  estimated  $131  to  $157  million annually  (Table  1). 
As  Cohen  et.  al.  reported,  most  of  the  cost is  for  hospital  expenses  followed 
by  productivity  loss  during  absence  from  work. 
III enough  to  see  a  doctor:  Again  the  two  methods  are  extensions  of  the 
surveillance data  and  the  outbreak data.  The  two  studies  of  a  sample  of  reported 
salmonellosis  surveillance  cases  in  1979-80  and  1984-5  found  that 22,000  of 
the  40,000  cases  saw  a  doctor without  being hospitalized  (Cohen  and  Tauxe, 
1986).  Extending  these  results  to  the  estimated  2  million U.S.  salmonellosis 
cases  annually,  the  number  of  cases  is  doubled  to  estimate  that 44,000  people 
see  a  doctor  (1987,  personal  communication). 
From  the  Illinois  outbreak  data  the  estimates  are  more  complicated  and 
still preliminary.  Six hundred  people  were  randomly  selected  from  the  16,000 
culture-confirmed  cases  and  sent a  questionnaire  asking  about  their illness. 
(318  of  the  600  answered  the  questionnaire).  Of  the  respondents  63%  reported 
seeing  a  physician either in  the  emergency  room  or  private  office  (C.  Ryan, 
1987,  personal  communication).  Assume  that  63%  of  the  16,000  confirmed  cases 
saw  a  physician and  that none  of  the  remaining  183,186  cases  saw  a  physician. , 
(This  conservative assumption  was  suggested  by  Caroline  Ryan,  CDC,  to  offset 
the  higher  than  average  rate of  people  seeking  medical attention because  of 
the  publicity and  the  possibility of  litigation against  the  dairy).  The  rate 
of  doctor visits  then  is  5.04%  for  the  whole  Chicago  outbreak,  or  (16,000  x 
.63)/200,000.  Multiplying  5.04%  times  the  U.S.  2  million estimated  cases, 
results  in an  estimated  101,000  doctor visits for  salmonellosis  annually. 
Costs  for  the  doctor visits are again updated  from  Cohen et al.  (Table 
2).  This  time  the  Physician Services  component  of  the  Consumer  Price  Index  is 
used  to  update  the  numbers  to  October  1987  values.  The  average  estimated cost -11-
for  persons  consulting  a  physician for  salmonellosis  is  $680.  Multiplied 
times  the  estimated  cases,  the  estimated  costs  for  these  cases  range  from  $30 
to  $69  million annually.  Hhile  physician expenses  and  laboratory  tests were 
the key  costs  cited  by  Cohen  et al.,  productivity  loss  is also  included  in  the 
estimate. 
Mild  cases:  I  assume  that  the  remainder  of  the  estimated  2  million cases 
are  mild  cases:  1,191,000  cases  using  extensions  of  salmonellosis  surveillance 
data  and  1,906,000  cases  using  extensions  of  the  outbreak data.  Cohen  et al. 
roughly  estimated  costs  for  these  people,  although  their  sample  size  was  small. 
Updated  to April  1987  dollars  using  the  change  in Average  Weekly  Earnings 
since  the  bulk  of  the  cost is  time  away  from  work,  the  costs  for  the  mild 
cases  are  roughly  estimated at  $221  apiece  (Table  1).  The  total costs  for 
mild  cases  are  estimated  to  range  between  $421  and  $424  million annually. 
In summary,  the  human  illness costs  of  salmonellosis  are  substantial. 
Medical  costs  and  lost productivity  add  up  to  a  low  estimate  of  $966  million 
annually  using  salmonellosis  surveillance data  and  a  high  estimate  of  $1.3 
billion annually  using  outbreak  data  for  salmonellosis  cases  (Table  2).  The 
difference  between  the  low  and  high  estimates  reflects  the  two  different methods 
of allocating  cases  into disease  severity categories. 
Discussion 
What  is  the  reliability of  the  above  estimates?  The  costs  for  the  four 
severity  levels are relatively  rough.  The  three  illness categories are  based 
on  a  survey  of  234  people  in an  outbreak  of  Salmonella heidelberg  contaminated 
cheddar  cheese  in Colorado  (Co~cn et al.,  1978).  Several  sources  of  bias are 
possible:  the  disease severity may  be  higher  or  lower  than average  depending 
on  the  Salmonella  serotype,  the  number  of  Salmonella  ingested,  and  the  age  and 
sex composition  of  the  people affected.  To  the  extent  this  outbreak is not  a 
"typical"  salmonellosis  outbreak,  there  is  the  possibility of  bias.  Of  particular -12-
concern  is  the  cost estimate for  the  mild  cases  because  so  few  of  these  cases 
were  in  the  sample  and  because  the  large  numbers  of  cases  make  these  cases  the 
first (surveillance  data)  or  second  (outbreak  data)  largest component  in  the 
estimatei. 
The  costs  for  the  deaths  are  reasonably reliable,  yet economists  still 
differ  on  the  best methodology.  The  human  capital  method  evaluated at a  10% 
interest rate is  one-fourth  of  the  adjusted  Landefeld  and  Seskin  method  used 
here,  and  the  willingness  to  pay  surveys  suggest  a  value  more  than  four  times 
higher. 
This  paper  contributes  to  the  epidemiological  literature on  salmonellosis 
by  reporting  two  methods  for  dividing  cases  into different severity groups: 
one  based  on  surveillance data  and  the  other  on  outbreak data.  Future  work 
will  refine  the  methods  for  estimating  the  number  of  cases  that belong  in  the 
severity categories  and  hopefully  increase  the  number  of  severity categories. 
Refinement  of  the  estimated  deaths  is particularly  important  because  of  their 
large  contribution  to  total estimated costs. 
The  one  billion dollar salmonellosis  cost estimate  excludes  several  factors 
which  may  be  significant  (Fig.  1).  Chronic  medical  conditions  resulting  from 
salmonellosis  are  excluded  from  the  estimates.  Salmonellosis  is occasionally 
followed  by  chronic  disease  such  as  rheumatoid  syndromes,  heart disease,  meningitis, 
colitis,  blood  poisoning,  thyroiditis  (Archer,  1984,  1985;  Cohen  and  Tauxe, 
1986;  Mossel,  1984).  What  we  don't know  is  the  likelihood of  occurance. 
Archer  has  estimated  that  2%  of  salmonellosis  patients will  end  up  with  reactive 
arthritis,  an  inflammation of  the  joints which  lasts  from  a  few  days  to  6 
months  (1985).  A fraction of  these  cases  will  continue  to  have  episodes  of 
arthritis.  Rheumatoid arthritis sufferers were  willing  to  pay  22  percent of 
household  income  to  be  rid  of arthritis in a  recent  survey  (Thompson,  1986). 
With  better incidence data,  costs  of  these  chronic  medical  conditions  could  be 
added  into  the  estimate. -13-
Other  costs  to  individuals  are  excluded.  For  example,  a  Canadian  economist, 
Leo  Curtin,  estimated  that  the  loss  of  leisure  time  was  greater  than  the  loss  of 
worktime  due  to  salmonellosis  (1984).  Estimates  using  his  methodology  of  valuing 
leisure  time  at  the  prevailing wage  rate would  more  than  double  the  cost of 
salmonellosis  estimates  presented  here. 
An  estimate for  inconvenience,  pain,  and  other relatively intangible  costs  to 
individuals  could  be  approximated  by  the  compensation approved  by  Circuit Judge 
John  Breen,  Jr.  for  the  Chicago  salmonellosis  victims  but still subject  to  appeal 
(Food  Chemical  News,  1987).  Those  sick  three  to  four  days  are  to  receive  $1,000 
plus  compensation  for  medical  expenses  and  lost work  time.  Those  sick  one  or  two 
days  will receive  $800  plus  the  compensation.  Individual  settlements are  to  be 
negotiated  for  those  sick  longer  than  four  days. 
Salmonellosis  can affect  the  productivity  of  poultry  thru  deaths  (McCapes, 
1987)  or  reduced  feed  efficiency and  reduced  weight gain  (Krug,  1985).  Other 
industry costs  of  salmonellosis  disease  outbreaks  include  plant cleanups  and  product 
recalls.  Ewen  Todd  found  that readily measurable  costs  associated  with  salmonellosis 
outbreaks  in  the  food  service  industry  ranged  from  $60,000  to  $700,000  per  outbreak 
(1985b)  while  costs  to  food  processors  ranged  from  $36,000  to  $3.3  million  per 
salmonellosis  outbreak  (1985a). 
Most  human  cases  of  salmonellosis  come  from  foodborne  sources  (Bryan,  1980; 
Cohen  and  Tauxe,  1986).  It is encouraging  that several  producer  groups,  such  as 
the  Southeastern Poultry  and" Egg  Association,  the  National  Broiler Council,  and 
the  American  Meat  Institute are  in  the  process  of  developing  good  manufacturing 
practices  to  reduce  Salmonella  contamination  levels. 
Researchers  also need  to  follow  the  charge  of  the  National  Academy  of 
Sciences  to  conduct  rigorous  risk assessments  to  better quantify  the  economic 
tradeoffs  for  controlling salmonellosis.  Reducing  pathogen  contamination  in 
foods  costs  money.  It may  require  changing  animal  husbandry  practices,  purchasing .' 
-14-
Salmonella-free  feed,  installing better refrigeration in meat  coolers,  reducing 
cross-contamination along  the  slaughter  line,  throwing  out over-age  food  sooner 
in grocery  stores  and  restaurants,  training  food  preparers  on  proper  food 
handling  and  sanitation  techniques,  or  implementing  new  technologies  such  as 
irradiation of  packaged  poultry  to kill Salmonella  (Curtin,  1984;  McCapes, 
1987;  Roberts,  1985).  We  don't know  yet which  combination of  strategies will 
have  the  greatest payoff  in reducing  foodborne  salmonellosis. 
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TABLE  1.  u.s.  salmonellosis  medical  costs  and  productivity  losses,  1987 
Salmonellosis  Estimated  cases  Updated  Total  costs 
severi  ty  Surveillance  Outbreak  costs  Surveillance  Outbreak 
categories  data  data  per  case  data  data 
--number-- dollars  million dollars 
Deathsl  1,000  2,000  354,600  355  709 
Hospi talized 
cases  36,000  30,000  4,350  157  131 
Only  saw  doctor  44,000  101,000  680  30  69 
Mild  cases 
(residual)  1,920,000  1,869,000  221  424  413 
Total  $966  million  to  $1.3  billion 
lDeaths  are also  assumed  to  be  hospitalized cases.  The  value  of  premature  death 
is updated  from  Landefeld  and  Seskin using  BLS'  Average  Weekly  Earnings  Index  • "  ) 
• 
TABLE  2.  Updated  costs  per  case  by  salmonellosis  severity in  Cohen  et ale 
Case  severity category  .  1976  costs  1987  costs  Index  used  to  update 
--dollars--
Hospitalized cases  1,750  4,350  Hospital Rooms/CPI 
Only  doctor visit  222  680  Physicians  Services/CPI 
III but no  doctor visit  125  221  Average  Weekly  Earnings 
Note:  All  updating  indexes  are  published  by  the  Bureau  of  Labor Statistics, 
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